Cargando…
CIP2A expression is increased in prostate cancer
BACKGROUND: The CIP2A protein is a recently characterized oncoprotein which inhibits protein phosphatase 2A activity. Expression of CIP2A has been detected in several carcinomas, but its expression and significance in prostate cancer has not been examined so far. METHODS: Expression of the CIP2A pro...
Autores principales: | Vaarala, Markku H, Väisänen, Marja-Riitta, Ristimäki, Ari |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984408/ https://www.ncbi.nlm.nih.gov/pubmed/20964854 http://dx.doi.org/10.1186/1756-9966-29-136 |
Ejemplares similares
-
Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer
por: VÄISÄNEN, MARJA-RIITTA, et al.
Publicado: (2013) -
Prognostic role of CIP2A expression in serous ovarian cancer
por: Böckelman, C, et al.
Publicado: (2011) -
Reciprocal regulation of CIP2A and AR expression in prostate cancer cells
por: Chuang, Hao-Wen, et al.
Publicado: (2022) -
High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer
por: Böckelman, C, et al.
Publicado: (2011) -
Transition to Targeted Therapies Improved the Prognosis and Increased the Utilization of Medical Treatments among Patients with Synchronous Metastatic Renal Cell Cancer
por: Laru, Lauri, et al.
Publicado: (2021)